• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Patient Information: The Future of Tumor Ablation Therapies

Article

RFA and other tumor ablation therapies are already widely used to treat liver tumors and to eliminate painful bone tumors. RFA treatment of liver tumors has been approved by the FDA for almost a decade, and some researchers recommend that RFA be the first-line treatment for tumors in that organ.

Researchers are currently studying the use of RFA and other tumor ablation methods for the following areas:
• Kidney
• Lung
• Breast
• Prostate
• Adrenal glands

The National Institutes of Health is conducting studies on RFA for the treatment of liver and kidney tumors and is also testing the efficacy of different equipment.
 

Related Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.